Clinical Trial Update: A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function [Phase 1]

View source ↗

Summary

Pfizer is conducting a Phase 1 study to learn how PF-07328948 is processed in people with reduced kidney function (renal impairment) and in healthy participants…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• PF-07328948

Snippet

Sponsor: Pfizer | Conditions: Renal Impairment, Healthy | Phase 1 | Status: RECRUITING